Phaedra Ghazi

6PUBLICATIONS
51CO-AUTHORS
Molecular targetsCancer geneticsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 22, 2026
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma.

|Aug 30, 2024
Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer.

Phaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram

|Feb 19, 2024
Inhibition of ULK1/2 and KRAS G12C controls tumor growth in preclinical models of lung cancer.

Phaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram

|Sep 16, 2020
Chloroquine Sensitizes GNAQ/11-mutated Melanoma to MEK1/2 Inhibition.

Amanda Truong, Jae Hyuk Yoo, Michael T Scherzer

|Apr 07, 2019
Tissue-Specific Oncogenic Activity of KRASA146T.

Emily J Poulin, Asim K Bera, Jia Lu

|Mar 01, 2018
Integrated in vivo multiomics analysis identifies p21-activated kinase signaling as a driver of colitis.

Jesse Lyons, Douglas K Brubaker, Phaedra C Ghazi

Pageof 1

Frequent Collaborators

4 joint publications

Martin McMahon

2 joint publications

Conan G Kinsey

2 joint publications

Guillermina Lozano

2 joint publications

Kevin M Haigis